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SUMMARY.-Spontaneouslyoccurring A-strain mouse mammarycarcinomata
were individually passaged, at equal intervals into separate groups of isogenic
hosts. The tumours showed evidence ofincreasing autonomy as judged either
by the decreasing host lymphoid hyperplasia they evoked, or their decreased
killing time, as passaging continued. However, in general, no reduction was
found in the ability of spleen cells from hosts bearing succeeding passages of
the same tumour to induce a graft-versus-host reaction in (A x CBA)Fl
hybrid mice. It is therefore suggested that the increasing malignancy of the
tumours studied was associated with a change in the tumour rather than
increasing immunodepression in successive hosts.
WHEN mouse tumours are serially passaged in their strain oforigin they show
evidence ofincreasing malignancy, as judged by the decreasing survival times of
hosts bearing successive transplant generations. This has been demonstrated
for mouse mammary carcinomataSymes (1965a) and leukaemias Miller andTaylor
(1948), Denton andSymes (1968).
Woodruff and Symes (1962a) demonstrated that on repeated transplantation
of mouse mammary carcinomata in the strain oforigin, thespleen andlymph nodes
ofthe hosts bearing the initial passages were hyperplastic and showed evidence of
immunological stimulation. However in later transplant generations the I mph y nodesandspleensbecam'enormoplastic. FurthermoreSymes(1965a)showedthat,
in a similar experiment, when the animals were allowed to die from the growth of
successive tumour passages the lymph nodes became grossly aplastic.
Intheory threepossibilitiesmight account for the abovefindings.
(i) A progressive decline in the immune responsiveness of the host, due to
tumour growth.
(ii) The deletion of tumour specific antigens with consequent removal of the
pointd'appui for the hosts immune response.
(iii) The production ofenhancing antibodies to tumour specific antigens. If
these were to be formed the tumour cells would become progressively more effec-
tively coatedby antibody on repeatedtransplantation.
The first possibility'involves a change in the host and is investigated in the
presentpaper. Thesecondandthirdhypotheses,involving achangeinthetumour,
are the subject of a second paper.122 JENNIFER A. REES AND M. 0. SYMES
MATERIALS AND METHODS
Generalplan of the experiment8
Young adult A-strain mice ofboth sexes maintained by strict brother x sister
mating have been usedthroughout.
Experiment I
Four spontaneously occurring A-strain mouse mammary carcinomata B24 to
B27 were separately passaged at intervals of 2 weeks through a series of A-strain
hosts. At varioustimes, up to 42days after tumourtransplantation, hostsbearing
succeeding passages of the tumour were killed. From each tumour bearing
host a spleen cell suspension was obtained and an aliquot was injected intraperi-
toneally into some members of an (A x CBA*)Fl hybrid litter, between 3 and 8
days old. Other members of the same litter received an equal number ofspleen
cells from a non-tumour bearing A-strain mouse. Within each litter there were
also one or more uninjected animals. Members of a given litter were killed 10
days afterinjection and theirspleen ratios determined. In this way a comparison
was made between theability ofspleen cells from tumour and non tumourbearing
hosts to induce a graft-versus-host reaction. An (A x CBA)F hybrid is for
genetic reasons unable toreject A-strain spleen cells. The A-strain cells therefore
react against the CBA antigens ofthe F, hybrid. The magnitude ofthis reaction
is a measure oftheirimmunological competence. Suchgraft-versus-host reactions
are maximal in young animals. The procedure for agiven litter is exemplified in
Table 1.
TABLE I.-Graft v. Ho,3t A8say-GvH Effect Produced by Injection of 20 X 106
Cell. From an A-Strain, Tumour-Bearing Mou8e into a Litterof(A x CBA)Fl
Hybrid Mice
Litters of age 3-8 days at start
Relative spleen weight = Wt of spleen mg.
Wt of mouse g.
Spleen ratio = Relative spleen wt of animal undergoing GvH
Mean relative spleen wt of control animals
Results from a typical litter: age 5 days at start
Mouse wt Spleen wt Relative Spleen Treatment 9- mg. Spleen wt ratio Mean
Injecting from tumour bearing 6
- 60 63-00 9-54 1-47 1.32=Ej A mouse 6- 90 52- 60 7- 62 1! 17
Injection from control A mouse 6- 60 69- 50 10-53 1-62 1. 61 =CT 6-30 65-60 10-41 1-60
Uninjected animals 6-60 42-60 6-45 -
6-60 43-00 6-52
Immunocompetence index = El 1-32 0-81 1-61
Table I shows, in detail, the results obtained from a single litter used in a
graft-versus-host (GvH) assay. The immunocompetence index is defined as
follows.
* A-strain mice are H2A and CBA, H2K.Mean spleen ratio for animals receiving spleen cells from a tumour bearing donor
Mean spleen ratio for animals receiving spleen cells from a non-tumour
bearing donor.
InFig. I arepresented theresults ofexperimentsdesigned to determine theability
ofmembers of agiven litter to demonstrate differences in spleen ratio arising from
injection of different numbers of spleen cells from animals without a tumour.
In every case the different doses of spleen ceUs injected were suspended in the
same volume of Medium 199. Simonsen (1962) has stated that a spleen ratio of
greaterthanl-3representsasignificantGvHreaction. Onthisbasisitmaybeseen
that the litter aged 2 days showed significant splenomegaly for all doses of cells
injected, and did notdistinguish between them.
However, three of four litters aged between 4 and 6 days showecl a spleen
ratio of between 1.2 and 1-3 only when 20 x 106 cells were injected. Therefore
in experiments to determine the immunocompetence index of animals with
QUANTITATrVE CONTROL EXPERIMENTS FOR GRAFr v HOST ASSAY
SPLEEN RATIOS OF (A x CBA)F1 HYBRID LITTERS, TEN DAYS AFTER
RECEIVING NORMAL A SPLEEN CELI, INJECTIONS
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FzG. 1.-Quantitative control experiments for graft v. host assay: Spleen ratios of (A X CBA)FI hybrid litters, ten days after receiving normal A spleen cell injections.124 JENNIFER A. REES AND M. 0. SYMES
tumours, litters older than 3 days were injected and, in the main, with 20 X 106
cells. In the results presented below any litters where spleen cells from the non-
tumourbearing mouse did not inducesignificantsplenomegaly, havebeenexcluded.
Experiment 2
This was a repeat of experiment I in which parallel evidence was sought for
increase in malignancy ofthe tumourbeing studied.
A single tumour B29 was seriallypassaged at intervals of 3 weeks in groups of
eight mice. Spleens from some animals bearing each transplant generation were
employed in a GvH assay as above, and the remaining animals were killed at 21
days. For the latter mice ipsilateral and contralateral lymph node weights and
relative spleen weights were determined as described in Symes (1965b).
For each passage in this experiment and in experiment 3 random samples of
tumour, lymph node and spleen were examined histolo-aicallv.
Experiment 3
This was similar to experiment 2, but the animals not killed for use in GvH
assays were allowed to die naturally. In this way the killing time of the tumour
in successivetransplant generations was determined. Thelymph node and spleen
weights of the several animals dying from progressive tumour growth were deter-
mined as above.
Method of tumour transplantation
Subcutaneoustransplants wereperformed as describedby WoodruffandSymes
(I962b).
Preparation ofspleen cell suspensions
The method of Woodruff and Symes (1962c) was used except that Medium 199
(Glaxo) was substituted for Hanks solution.
RESULTS
Experiment I
The immunocompetence indices of animals bearing successive passages of
tumours B24 to B27 forvaryingperiods oftime are shown in Table 11. If aspleen
ratio of 1.3 denotes a significant GvH reaction and a ratio of 1-0 no reaction a
significantly reduced immunocompetence index may be 1/1-3 0-76. There was
no significant decline in the index in animals bearing successive passages of agiven
tumour for the same length of time. However, the index did fall in two out of
three cases where comparison can be made between separate hosts bearing trans-
plants from the same tumour passage for increasing periods of time. This may
be seenby reference to passage I of tumour B26, and passage II oftumour B26.
Experiment 2
The results of experiment I suggested host immunodepression was not a deter-
mining factor in the increasing malignancy of tumours associated with their
prolongedgrowth. It therefore seemed desirable to repeat these observations and
at the same time confirm a change in the behaviour of the tumour under study.INCREASING MALIGNANCY OF TUMOURS 125
TABLF, II.-Immunocompetence Indexfor A-Strain Mice Bearing Successive
Passages ofFour Different A-Strain Mammary Carcinomata
Time for which tumour was present
(days)
Passage No. 14 28 42
1 1-25*** 0-72* 0
- 75***
0-96*** 0
-66**
0-84****
2 0
-97***
3 0
- 85*** 1.01****
4 0
-96*** 0
- 98***
0-84****
5 0
- 74****
6
7
8 0-53***
9
10
II 0
- 89*** 0-78***
12 0.91***
Key: Tumour B24*
Tumour B25**
Tumour B26***
Tumour B27****
Symes (1965b) postulated that the immunological response of the host to the
specific antigens of a given subcutaneous tumour follows a regular cycle, as
the antigens are deleted during progressive tumour growth. Firstly there is
hyperplasia ofthe axillary and inguinallymph nodes, both ipsilateral and contra-
lateral, with reference to the tumour site. Then as thelymph nodes arereturning
to their normal weight, hyperplasia of the spleen commences'and is for a time
progressive before it ultimately returns to normal. It is suggested that these
changes represent increasingly vigorous, but ultimately abortive- attempts by the
host to respond to the tumour. This cycle was reproduced by the ipsilateral
lymph nodes and spleen (although the spleen had not returned to a normoplastic
state when the experiment, was terminated) on serial passage of tumour B29
(Fig. 2). At the same time there was no decline in the immunocompetence index
TABLIF, III.-Immunocompetence Indexfor A-Strain Mice Bearing Successive
Passages of Tumour B29 or B30
Time for which tumour was present (days)
Passage No. 14 21 28 35 42
1 0.90 1.00
0-88*
2 0- 82 1-08 0- 87
0-82*
3 1-05
4 0-72 1-06* 0.99*
5 0-96
6 0-85
0-71
8 0-95 0-68
9 0-62
0-89
10 0-94
Key: Tumour B29
Tumour B30*Ipsilateral Lymph
Node Weights
461 161
51 151
= S.D.
[ I = Ha OF ANIMALS
- -- MEAN OF CONTROLS
I I I I I 1 2 3 z 5 i 7 a 9 10
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ofanimals carrying successive passages ofthe tumour for the samelength oftime
(Table III).
Experiment 3
The killing time of tumour B30 was found to decrease when passages I and 2
are compared with 3 and 4 (Table IV).
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FIG. 2.-Mean relative spleen weights plus ipsilateral and contraJateral lymph node weights, of
groups of A-strain mice with successive passage's of tumour B29 for three weeks.MEAN RELATIVE SPLEEN WEIGHI'S PLU-S IPSILATERAL AND CONTRALATERAL
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TABLE IV.-Day of Death ofA-Strain Mice Bearing SUCM8iVePa88age8
ofMammary Carcinoma B30
Mean day of death ± I.S.D.
(brackets indicate No. ofobservations)
47-2± 8-56 (6)
46-6±13-56 (7)
31-8± 6-97 (6)
33-6± 5-41 (5)
Passage No.
1
2
3
4
ttive Spleen
Weight
[ ] = Number of Animals
. Standard Deviation
of Sample
lassage
lo- 1-4v.
FIG. 3.-Mean relative spleen weights plus ipsilateral and contralateral lymph node weights of
groups of A-strain mice, at death, due to growth of tumouir B30.128 JENNIFER A. REES AND M. O.'SYMES
An analysis ofthe varianceperformed on the survival times showed that over
the fourtransplantgenerations, the decrease in survivaltimes wassignificant atthe
0-1% level (i.e. P > 0.001).
The ipsilateral and contralateral lymph nodes of animals carrying successive
transplant generations of B30 were in all cases grossly hypoplastic, whilst the
spleens were initially hyperplastic, but became normoplastic as passaging contin-
ued (Fig. 3). These changes are in accord with those previously described under
similar conditions by Symes (1965a).
At the same time there was no significant reduction in the immunocompetence
index in animals bearing the first or fourth transplant generations ofthis tumour
for 42 days, or the second generation for 21 days (Table 111).
Histology
There was no change seen in the appearance of tumour B29 on serial trans-
plantation. In all cases the tumour was poorly differentiated.
With tumour B30, the tumour in the autochthonous host and in the first two
transplant generations showed evidence of differentiation into gland acini with
ducts. In the third and fourthtransplantgenerations this differentiation was less
marked and such ducts as were present showed incomplete epithelial linings.
The host ipsilateral lymph nodes in the third passage of tumour B29, showed
hyperplasia in the thymus dependent deep cortical areas.
No evidence of lymph node stimulation was seen in hosts bearing the other
passages oftumourB29, or in the animalscarrying any passage ofB30.
The spleens in animals oftheeighth and ninth passages oftumour B29 showed
marked hyperplasia of the Malpighian follicles, the splenic white pulp being mar-
kecHy active in the ninth passage.
DISCUSSION
The results presented above confirm that on serial subcutaneous passage of
A-strain mouse mammary carcinomata in the strain of origin, the killing time
of the tumour decreases. Pari passu the immunological response to the tumour
involves first theperipherallymphoid tissue and.later, when this becomes exhaus-
ted, the spleen. In this connection it is postulated that the spleen-functions as a
central immunological reserve.
At the same time as these changes are occurring, there is no decline in the
immunological competence of spleen cells from the tumour bearing hosts, as
assayed by their ability to react against third-party antigens.
It is thereforesuggestedthatthefundamentalchange involvedintheincreasing
malignancy of the tumour is a change in the tumour cells themselves rather than
in the host's immunological response thereto.
This finding is somewhat at variance with the results of others. Linder
(1962) found a prolonged survival of skin allografts in mice with spontaneous
mammary carcinomata and carcinogen induced sarcomata. In addition
Stjemsward (1967) demonstrated that in mice receiving a single injection of
3-methyleholanthrene, there was prolonged depression of the response to weakly
antigenic skin allografts during the latent period before a tumour appeared.
Stjernsward (1968) also found that following excision of the tumour bearing hind
limb of a mouse, treated with 3-MC, this animal supported the growth of a re-
challenge with its own tumour better than did a shamamputatedisogenic control.INCREASING MALIGNANCY OF TUMOURS 129
It would therefore seem of interest to repeat the findings reported in the present
paper, using a carcinogen induced tumour.
However, that a change in tumour rather than host is involved in the present
system is furthersupportedby thefollowing evidence.
(i) Five mammary carcinomata were separately transplanted from the auto-
chthonous host to further isogenic hosts as three subcutaneous transplants
i
each case. For each tumour a transplant was excised at 14, 28 or 42 days after
implantation and transferred to a further host. Tumour growth rate and the
survival time of this second host, were respectively directly and inversely propor-
tional to theperiod for which the tumour waspresent in the firstgeneration host.
(ii) A mammary carcinoma passaged through two isogenic hosts grew at the
same rate onre-transplantation as a tumour maintained for the same time in one
host. The tumour maintained in one host was excised and transplanted to the
opposite side at the same time as the first tumour line waspassaged to the second
host.
When this experiment wasrepeated with a second tumour the line maintained
in one host grew faster than that maintained by serial transplantation through three hosts.
These findings will be reported in detail later.
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